Larvol Delta - Targeting-IRAK4-with-Emavusertib-in-Lymphoma-Models-with-Secondary-Resistance-to-PI3K-and-BTK-Inhibitors

emavusertib (CA-4948) - Curis, Dr. Reddy’s

http://www.ncbi.nlm.nih.gov/pubmed/36675328

Jan 22, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next